We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Sullivan & Cromwell Reps Valeant In $5.7B Cephalon Bid

Law360 (March 29, 2011, 9:16 PM EDT) -- Valeant Pharmaceuticals International Inc. on Tuesday announced a $5.7 billion bid to buy Cephalon Inc., making a public appeal to the biopharmaceutical company's shareholders.

Neurology and dermatology pharmaceutical developer Valeant offered...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.